Savill Corrine (CIK 1837524) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-21). Recent activity: Buy CGEM (37,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-21 | Cullinan Therapeutics, Inc. (CGEM) | Chief Business Officer | Buy | 37,500 | $0 |
Source: SEC Form 4 filings · as of 2025-02-21